Seeking Alpha

Immunovaccine Inc. (IMMVF)

We currently have no Breaking News on this stock.
Visit Seeking Alpha's
IMMVF vs. ETF Alternatives
Company Description
Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company's DeopVax platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation... More
Sector: Healthcare
Industry: Biotechnology
Country: Canada